StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Evercore ISI Upgrades Sarepta Therapeutics (SRPT) to Outperform
August 8, 2024 8:18 AM
Evercore ISI analyst Gavin Clark-Gartner upgraded Sarepta Therapeutics (NASDAQ: SRPT) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Upgrades
Next Articles
Sarepta Therapeutics (SRPT) PT Lowered to $205 at Needham
August 8, 2024 7:47 AM
Sarepta Therapeutics (SRPT) PT Lowered to $200 at Piper Sandler
August 8, 2024 7:41 AM
Sarepta Therapeutics (SRPT) PT Lowered to $181 at RBC Capital
August 8, 2024 6:27 AM
Sarepta Therapeutics (SRPT) PT Lowered to $203 at Barclays
August 8, 2024 5:12 AM
Form S-8 Sarepta Therapeutics,
August 7, 2024 4:53 PM
Sarepta Therapeutics falls on revenue miss, weak outlook
August 7, 2024 4:50 PM
Sarepta Therapeutics (SRPT) Tops Q2 EPS by 57c, provides guidance
August 7, 2024 4:19 PM
Sarepta Therapeutics Announces Second Quarter 2024 Financial Results and Recent Corporate Developments
August 7, 2024 4:05 PM
Form 10-Q Sarepta Therapeutics, For: Jun 30
August 7, 2024 4:02 PM
